Malaria vaccine, Mosquirix, gets OK for use outside the EU

In a follow-up to a report from 2012, the European Medicines Agency's Committee for Medicinal Products for Human Use(CHMP) has adopted a positive scientific opinion for Mosquirix (Plasmodium falciparum and hepatitis B vaccine), for use outside the European Union (EU). The malaria vaccine Mosquirix, also known as RTS,S/AS01, was submitted to EMA under a regulatory procedure ["]